UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$321M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$214M |
| 3 |
Zimmer Biomet
ZBH
|
+$207M |
| 4 |
Ecolab
ECL
|
+$192M |
| 5 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$251M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$225M |
| 3 |
AGN
Allergan Inc
AGN
|
+$221M |
| 4 |
Apple
AAPL
|
+$201M |
| 5 |
American Express
AXP
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.57% |
| 2 | Technology | 14.63% |
| 3 | Financials | 14.16% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIVO
2176
DELISTED
Meridian Bioscience Inc
VIVO
| $313K | ﹤0.01% |
16,399
+1,100
| +7% | +$20.3K |
|
|
REV
2177
DELISTED
Revlon, Inc.
REV
| $313K | ﹤0.01% |
7,600
+400
| +6% | +$13.8K |
|
2178
Builders FirstSource
BLDR
$7.29B
| $312K | ﹤0.01% |
46,698
+1,600
| +4% | +$9.99K |
|
2179
Ingles Markets
IMKTA
$1.72B
| $312K | ﹤0.01% |
6,300
+200
| +3% | +$8.99K |
|
2180
Orthofix Medical
OFIX
$492M
| $312K | ﹤0.01% |
+8,700
| New | +$273K |
|
|
LABL
2181
DELISTED
Multi-Color Corp
LABL
| $312K | ﹤0.01% |
4,500
+200
| +5% | +$12.7K |
|
2182
Myers Industries
MYE
$1.24B
| $309K | ﹤0.01% |
17,599
+600
| +4% | +$10.6K |
|
|
LORL
2183
DELISTED
Loral Space and Communications, Inc.
LORL
| $308K | ﹤0.01% |
4,500
| – | – |
|
2184
PLDT
PHI
$4.32B
| $307K | ﹤0.01% |
4,915
| – | – |
|
2185
Intrepid Potash
IPI
$476M
| $305K | ﹤0.01% |
2,640
+160
| +6% | +$21.1K |
|
2186
Middlesex Water
MSEX
$1.07B
| $305K | ﹤0.01% |
13,400
| – | – |
|
2187
National CineMedia
NCMI
$378M
| $305K | ﹤0.01% |
2,020
+110
| +6% | +$16.4K |
|
2188
Geron
GERN
$898M
| $304K | ﹤0.01% |
80,500
-24,100
| -23% | -$81.8K |
|
2189
SiriusPoint
SPNT
$3.03B
| $304K | ﹤0.01% |
21,500
+4,600
| +27% | +$63.8K |
|
|
BLT
2190
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $304K | ﹤0.01% |
23,598
+2,100
| +10% | +$32.3K |
|
2191
Accuray
ARAY
$27.5M
| $303K | ﹤0.01% |
32,597
+1,900
| +6% | +$15.1K |
|
|
EMBJ
2192
Embraer S.A. ADS
EMBJ
$12B
| $303K | ﹤0.01% |
9,852
| – | – |
|
2193
McGrath RentCorp
MGRC
$2.87B
| $303K | ﹤0.01% |
9,200
+500
| +6% | +$16K |
|
2194
M/I Homes
MHO
$3.95B
| $303K | ﹤0.01% |
12,699
+3,000
| +31% | +$65.6K |
|
|
NMBL
2195
DELISTED
Nimble Storage, Inc.
NMBL
| $303K | ﹤0.01% |
13,600
+1,000
| +8% | +$24.3K |
|
|
ACI
2196
DELISTED
ARCH COAL, INC.
ACI
| $303K | ﹤0.01% |
30,272
+14,623
| +93% | +$170K |
|
|
IPCM
2197
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
| $303K | ﹤0.01% |
6,500
+300
| +5% | +$13.1K |
|
|
CONE
2198
DELISTED
CyrusOne Inc Common Stock
CONE
| $302K | ﹤0.01% |
9,700
+800
| +9% | +$23.6K |
|
|
CKEC
2199
DELISTED
Carmike Cinemas Inc
CKEC
| $302K | ﹤0.01% |
9,000
+500
| +6% | +$14.8K |
|
2200
Stratasys
SSYS
$666M
| $301K | ﹤0.01% |
5,700
| – | – |
|
Similar funds
UBS AM's Q1 2015 Portfolio in Review
As of Q1 2015, UBS AM held 2,695 positions worth $104B, down 1.3% from $105B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM withdrew a net $4.3B in Q1 2015, closing 72 positions and reducing 841 holdings. Its most notable exit was Allergan Inc, an estimated $221M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, UBS AM opened a new position in Qorvo worth $36M.
- UBS AM's largest Q1 2015 buy was Qorvo: 451,878 shares worth $36M.
- UBS AM added most to Allergan plc in Q1 2015, an estimated $321M increase.
- UBS AM's biggest Q1 2015 reduction was Walgreens Boots Alliance, cutting an estimated $251M.
- UBS AM fully exited Allergan Inc in Q1 2015, selling an estimated $221M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q1 2015.
- UBS AM opened 84 new positions and closed 72 in Q1 2015.
- UBS AM's portfolio value fell 1.3% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.